Corresponding Author: Peter Anderyas, MBBS, St Vincent’s Hospital Melbourne, 41 Victoria Parade, Fitzroy, VIC 3065, Australia (peter.anderyas@svha.org.au).
Published Online: October 24, 2022. doi:10.1001/jamaneurol.2022.3479
Conflict of Interest Disclosures: None reported.
Additional Contributions: We thank the patient for granting permission to publish this information. We also acknowledge and thank Penny McKelvie, MBBS (St Vincent’s Hospital Melbourne), for providing pathology images and interpretation; compensation was not received.
1.Sophie
NMB , Klein
CJ , Waters
P , Pittock
SJ , Irani
SR . LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.
J Neurol Neurosurg Psychiatry. 2018;89(5):526-534. doi:
10.1136/jnnp-2017-315720Google ScholarCrossref 2.Irani
SR , Alexander
S , Waters
P ,
et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia.
Brain. 2010;133(9):2734-2748. doi:
10.1093/brain/awq213PubMedGoogle ScholarCrossref